Pathogenesis of Malignant Pleural Effusions and Talc Pleurodesis[1]

 

 Permissions and Reprints

In this review I hope to cover two critical areas, namely the mechanism of formation of malignant pleural effusions and the treatment of malignant pleural effusions via pleurodesis. The pathogenesis of malignant pleural effusions involves several steps. These allow the malignant cell to separate from the primary tumor, dock onto the area of the metastatic site, transmigrate through the pleural membrane and initiate autocrine proliferation. The role of several factors including integrins and hyaluronan will be described. I will use the role of the glycosaminoglycan, hyaluronan, and its interaction with the CD44 receptor to illustrate the mechanisms of metastatic tumor formation on the pleural surface.

Since talc pleurodesis remains the mainstay of treatment for malignant pleural effusions, this review will discuss the inflammatory responses induced by talc and the mechanisms of talc induced fibrosis. The concept that the normal mesothelium plays a critical role in the development of pleural fibrosis will be introduced. The possibility that talc may serve other functions besides the induction of pleural fibrosis will be discussed.

1 Herrn Prof. Dr. R. Loddenkemper, Berlin, zum 60. Geburtstag gewidmet

Literature

• 1 Jiang W. In vitro models of cancer invasion and metastasis: recent developments.  Eur J Surg Oncol. 1994;  20 493-499
  PubMedGoogle Scholar
• 2 Zetter B. Adhesion molecules in tumor metastasis.  Semin Cancer Biol. 1993;  4 219-229
  PubMedGoogle Scholar
• 3 Sneath R J S, Managham D C. The normal structure and function of CD44 and its role in neoplasia.  J Clin Pathol Mol Pathol. 1998;  51 191-200
  PubMedGoogle Scholar
• 4 Koukoulis G K, Patriarca C, Gould V E. Adhesion molecules and tumor metastasis.  Human Pathol. 1998;  889-891
  PubMedGoogle Scholar
• 5 Trochon V, Mabilat C, Bertrand P et al. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro.  Int J Cancer. 1996;  66 664-668
  CrossrefPubMedGoogle Scholar
• 6 Bourguignon L, Lokeshwar V, Chen X et al. Hyaluronic acid induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.  J Immunol. 1993;  1551 6634-6644
  PubMedGoogle Scholar
• 7 Menzel E J, Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Letters 1998: 3-11
• 8 Johnson J P. Cell adhesion molecules of the immunoglobin supergene family and their role in malignant transformation and progression to metastatic disease.  Cancer Metastasis Rev. 1991;  10 11-12
  CrossrefPubMedGoogle Scholar
• 9 Bukholm I K, Nesland J M, Karesen R et al. E-Cadherin and α, β- and γ-catenin protein expression in relation to metastasis in human breast carcinoma.  J Pathol. 1998;  185 262-266
  PubMedGoogle Scholar
• 10 Underhill C. CD44: the hyaluronan receptor.  J Cell Sci. 1992;  103 293-298
  PubMedGoogle Scholar
• 11 Ponta H, Wainwright D, Herrlich P. Molecules in focus: The CD44 protein family.  Int J Biochem Cell Biol. 1998;  30 299-305
  CrossrefPubMedGoogle Scholar
• 12 Hott J W, Godbey S W, Antony V B. The role of the mesothelial cell in pleural metastasis; Inhibition of breast carcinoma cell adherence to pleural cells by hyaluronidase.  FASEB J. 1992;  6 (5) 1919
  PubMedGoogle Scholar
• 13 Hott J W, Godbey S W, Antony V B. The role of the mesothelial cell in pleural metastasis: Breast carcinoma cell adherence to pleural mesothelial cells by a mechanism involving hyaluronate and CD44.  Am Rev Respir Dis. 1993;  147 (4) A794
  PubMedGoogle Scholar
• 14 Hott J W, Yu L, Godbey S W, Holm K A, Antony V B. The role of the mesothelial cell in pleural metastasis; breast carcinoma cell proliferation in response to a pleural mesothelial cell derived growth factor.  Am J Respir Crit Care Med. 1996;  153 (4) A44
  PubMedGoogle Scholar
• 15 Seiter S, Arch R, Reber S, Komitowski D, Ponta M, Ponta H, Matzku S, Zoller M. Prevention of tumor metastasis formation by anti-variant CD44.  J Exp Med. 1993;  177 443-455
  CrossrefPubMedGoogle Scholar
• 16 Naor D, Sionov R V, Shalom D I. CD44: structure, function and association with the metastatic process.  Adv Can Res. 1997;  71 241-319
  PubMedGoogle Scholar
• 17 Hott J W, Yu L, Antony V B. Mechanisms of pleural metastasis: MCF-7 breast adenocarcinoma cell haptotaxis to hyaluronic acid.  Am J Resp Crit Care Med. 1997;  155 A180
  PubMedGoogle Scholar
• 18 Bennett K L, Jackson D G, Simon J C, Tanczos E, Modrell R, Modrell B, Stamenkovic I, Plaowman G, Aruffo A. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor.  J Cell Biol. 1995;  128 687-698
  CrossrefPubMedGoogle Scholar
• 19 Zawadzki V, Perschl A, Rosel M, Hekele A, Zoller M. Blockade of metastasis formation by CD44-receptor globulin.  Int J Cancer. 1998;  75 919-924
  CrossrefPubMedGoogle Scholar
• 20 Ozer E, Canda T, Kurtoolu B. The role of angiogensis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas.  Cancer Letters. 1997;  122 119-123
  PubMedGoogle Scholar
• 21 Stetler-Stevenson W G. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.  Clin Invest. 1999;  103, #9 1237-1241
  PubMedGoogle Scholar
• 22 Eliceiri B P, Cheresh D A. The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development.  Clin Invest. 1999;  103, #9 1227-1230
  PubMedGoogle Scholar
• 23 Isner J M, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.  The Journal of Clinical Investigation. 1999;  103, #9 1231-1236
  PubMedGoogle Scholar
• 24 Hott J W, Yu L, Antony V B. Role of VEGF in the formation of malignant pleural effusions.  Am J Respir Crit Care Med. 1999;  159 A212
  PubMedGoogle Scholar
• 25 Galffy G, Mohammed K A, Ward M J, Dowling P A, Antony V B. Interleukin 8 - An autocrine growth factor for malignant mesothelioma.  Am Cancer Res. 1999;  59 367-371
  PubMedGoogle Scholar
• 26 Bethune N. Pleural poudrage: a new technique for the deliberate production of pleural adhesions as a preliminary to lobectomy.  J Thorac Surg. 1935;  4 251-261
  PubMedGoogle Scholar
• 27 Loddenkemper R. Thoracoscopy - state of the art.  Eur Respir J. 1998;  11 213-221
  CrossrefPubMedGoogle Scholar
• 28 Rodriquez-Panadero F, Antony V B. Pleurodesis: state of the art.  Eur Respir J. 1997;  10 1648-1654
  CrossrefPubMedGoogle Scholar
• 29 Walker-Renard P B, Vaughan L M, Sahn S A. Chemical pleurodesis for malignant pleural effusions.  Ann Int Med. 1994;  120 56-64
  CrossrefPubMedGoogle Scholar
• 30 Kennedy L, Vaughan L M, Steed L L, Sahn S A. Sterilization of talc for pleurodesis: available techniques, efficacy and cost analysis.  Chest. 1995;  107/4 1032-1034
  PubMedGoogle Scholar
• 31 Heuvel M M, Smith H J M, Barbierato S B, Havenith C EG, Beelen R HJ, Postmus P E. Talc-induced inflammation in the pleural cavity.  Eur Respir J. 1998;  12 1419-1423
  CrossrefPubMedGoogle Scholar
• 32 Rodriguez-Panadero F, Segado A, Martin Juan J, Ayerbe R, Torres Garcia I, Castillo J. Failure of talc pleurodesis is associated with increased pleural fibrinolysis.  Am J Respir Crit Care Med . 1995;  785-790
  PubMedGoogle Scholar
• 33 Nasreen N, Hartman D L, Mohammed K A, Antony V B. Talc-induced expression of C-C and C-X-C chemokines and intercellular adhesion molecule-1 in mesothelial cells.  Am J Respir Crit Care Med. 1998;  158 971-978
  PubMedGoogle Scholar
• 34 Antony V B, Kamal M A, Godbey S, Loddenkemper F W. Talc induced pleurodesis: Role of basic fibroblast growth factor (bFGF).  Eur Respir J. 1997;  10 403S
  PubMedGoogle Scholar
• 35 Colt H G, Russack V, Chiu Y, Konopka R G, Chiles P G, Pedersen C A, Kapelanski D. A comparison of thoracoscopic talc insufflation, slurry and mechanical abrasion pleurodesis.  Chest. 1997;  111/2 442-448
  PubMedGoogle Scholar
• 36 Nasreen N, Mohammed K A, Dowling P A, Ward M J, Galffy G, Antony V B. Talc induces apoptosis in human malignant mesothelioma cells in vitro.  Am J Respir Crit Care Med. 1998;  157 (3) A63
  PubMedGoogle Scholar

1 Herrn Prof. Dr. R. Loddenkemper, Berlin, zum 60. Geburtstag gewidmet

MD Veena B. Antony

Professor of Medicine and Pediatrics Indiana University School of Medicine Chief, Pulmonary and Critical Care Medicine RL Roudebush VA Medical Center

1481 West 10th Street

Indianapolis, IN 46202

USA

Email: vantony@iupui-edu